1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-41.82%
Both companies show declining cash positions (-41.82% vs CRON.TO's -0.43%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
3.77%
Higher Short-Term Investments Growth compared to CRON.TO's zero value, indicating better performance.
-1.62%
Cash + STI yoy ≥ 1.5x CRON.TO's -0.41%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
31.32%
Receivables growth 1.25-1.5x CRON.TO's 23.99%. Martin Whitman would worry that the company may be booking revenue too aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.39%
Below half of CRON.TO's 0.93%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.39%
Below half of CRON.TO's 1.85%. Michael Burry sees a potential red flag for stagnation or capital shortage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-40.98%
50-75% of CRON.TO's -76.92%. Bruce Berkowitz notes a more controlled liability line.
-40.98%
Less than half of CRON.TO's 13.81%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-40.98%
Less than half of CRON.TO's 15.26%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-15.26%
≥ 1.5x CRON.TO's -8.57%. David Dodd sees higher yoy retained profits than competitor.
No Data
No Data available this quarter, please select a different quarter.
3.77%
Higher Other Stockholders' Equity Items Growth compared to CRON.TO's zero value, indicating worse performance.
0.86%
0.5-0.75x CRON.TO's 1.49%. Martin Whitman is wary of lagging equity growth vs. competitor.
-1.39%
Below half CRON.TO's 1.85%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
3.77%
Below half CRON.TO's -1.18%. Michael Burry suspects major underinvestment or forced divestment.
No Data
No Data available this quarter, please select a different quarter.
41.82%
Above 1.5x CRON.TO's 0.45%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.
